Literature DB >> 6489161

Baclofen toxicity associated with declining renal clearance after ibuprofen.

P A Dahlin, J George.   

Abstract

A 64-year-old male with an incomplete spinal cord injury had been taking baclofen 20 mg tid for 2 1/2 months without side effects. His blood urea nitrogen and serum creatinine rose from 13 and 0.9 mg%, respectively, to 59 and 2.8 mg% after ibuprofen 600 mg tid was begun. The patient displayed baclofen toxicity, developing confusion, disorientation, bradycardia, and hypothermia. His blood pressure dropped and he complained of blurred vision. Ibuprofen discontinuation and fluid repletion corrected the renal indices. Rapid tapering of baclofen was accompanied by reversal of baclofen toxicity. Patients taking baclofen must be monitored closely for toxicity when declining renal function is present. Clinicians should be alert to the possibility of renal insufficiency developing when ibuprofen is initiated. This case demonstrates the potential for ibuprofen-induced renal insufficiency to reduce baclofen clearance, thereby leading to baclofen toxicity. Published reports of ibuprofen-induced renal insufficiency are reviewed and pertinent pharmacokinetics of baclofen discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489161     DOI: 10.1177/106002808401801006

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  7 in total

Review 1.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

2.  Transient alteration of consciousness in spinal cord injury secondary to Baclofen use: a case report.

Authors:  Thomas John Pisano; Jessica Ace; Beverly Hon
Journal:  Spinal Cord Ser Cases       Date:  2022-05-21

Review 3.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Pharmacokinetics of baclofen in spastic patients receiving multiple oral doses.

Authors:  E W Wuis; M J Dirks; T B Vree; E Van der Kleijn
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

5.  Plasma and urinary excretion kinetics of oral baclofen in healthy subjects.

Authors:  E W Wuis; M J Dirks; E F Termond; T B Vree; E Van der Kleijn
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Encephalopathy and hypotonia due to baclofen toxicity in a patient with end-stage renal disease.

Authors:  Mohsin Ijaz; Hassan Tariq; Muhammad Kashif; Jose Gomez Marquez
Journal:  Am J Case Rep       Date:  2015-04-20

7.  Low-Dose Baclofen-Induced Encephalopathy in a Healthy Young Adult: Is Baclofen Toxicity Dose-Dependent?

Authors:  Emeka Ibeson; Ifeanyi Nwosu; Thai Donenfeld; Britney Clemen; Ufeh Annabel Ogar; Omosefe E Ogbeifun; Michael Marcelin
Journal:  Cureus       Date:  2021-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.